Rchr
J-GLOBAL ID：200901041153976640   Update date: Jan. 30, 2024

Echizen Hirotoshi

エチゼン ヒロトシ | Echizen Hirotoshi
Affiliation and department：
Meiji Pharmaceutical University

About Meiji Pharmaceutical University


Research field  (3)： Internal medicine - General ,  Gastroenterology ,  Pharmacology
Research keywords  (4)： 消化器内科学 ,  臨床薬理学 ,  Gastroenterology ,  Clinical Pharmacology
Research theme for competitive and other funds  (10)：
  • 2008 - 2010 Individualization of anticoagulation therapy of warfarin based on pharmacogenetic information
  • 2000 - 2010 薬物応答性の個人差と薬理ゲノム学
  • 2000 - 2010 薬物相互作用の予測
  • 1996 - 2010 Drug interaction
  • 2006 - 2009 Studies on the urinary assay of CYP-mediated endogenous corticosteroid metabolites with a LC-MS method
Show all
Papers (179)：
  • Yasumasa Tsuda, Masahiro Takahashi, Fumiya Watanabe, Kazumi Goto, Hirotoshi Echizen. Population Pharmacokinetic Analysis of Vancomycin in Patients with Solid or Hematological Malignancy in Relation to the Quick Sequential Organ Failure Assessment Scores. European journal of drug metabolism and pharmacokinetics. 2023
  • Daisuke Nango, Tuyoshi Sekizuka, Makoto Goto, Hirotoshi Echizen. [Analysis of Information on Drug Adverse Reactions Using U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2022. 142. 4. 341-344
  • 朝田 瑞穂, 永田 将司, 高橋 弘充, 越前 宏俊, 安原 眞人. 日常の疑問・問題点からTDM研究への第一歩〜問題解決までの取り組み方〜 人工心肺施行中の抗菌薬の薬物動態に関する研究. TDM研究. 2021. 38. 2. 57-57
  • Momoko Suzuki, Ryuichi Ogawa, Hirotoshi Echizen, Hiroshi Kogen, Kenichi Kobayashi. Concise synthesis of the major metabolite M8 from ticagrelor and simultaneous determination of ticagrelor and M8 by a novel LC/MS method. Journal of Chemical Research. 2021. 45. 7-8. 174751982199199-174751982199199
  • Mizuho Asada, Masashi Nagata, Tomohiro Mizuno, Tokujiro Uchida, Hiromitsu Takahashi, Koshi Makita, Hirokuni Arai, Shinichi Kijima, Hirotoshi Echizen, Masato Yasuhara. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery. European Journal of Clinical Pharmacology. 2020
ｍore...
MISC (386)：
ｍore...
Books (1)：
  • 図解薬理学ー病態から考える薬物治療へのアプローチ 第二版
    医学書院 2008
Lectures and oral presentations  (143)：
  • チロシンキナーゼ阻害薬に対するH2受容体拮抗薬とプロトンポンプ阻害薬の影響に関するメタ解析
    (日本薬学会年会要旨集 2020)
  • 定量的構造活性相関(QSAR)解析を用いた薬物クリアランスの予測
    (日本薬学会年会要旨集 2020)
  • 定量的構造活性相関(QSAR)解析を用いた分布容積の予測
    (日本薬学会年会要旨集 2020)
  • UPLC-MSを用いた尿中6位水酸化コルチゾールおよびコルチゾール定量法の開発
    (日本薬学会年会要旨集 2020)
  • 血液透析時の薬物透析性を定量的に予測するためのQSAR解析と生理学的速度論解析
    (日本薬学会年会要旨集 2020)
ｍore...
Education (1)：
  • 1972 - 1978 Hokkaido University School of Medicine
Professional career (1)：
  • (BLANK)
Work history (9)：
  • 2020/04 - 現在 Meiji Pharmaceutical University President
  • 2019/04 - 2020/03 Meiji Pharmaceutical University Specially appointed Professor
  • 1995/04 - 2019/03 Meiji Pharmaceutical University Department of Pharmacotherapy Professor
  • 1994/04 - 1995/03 Kitasato University, School of Medicine Department of Pharmacology Assistant Professor
  • 1986/10 - 1994/03 National Institute of Health and Nutrition Department of Adult Nutrition Senior Fellow
Show all
Association Membership(s) (4)：
Japanese Society of Clinical Pharmacology and Therapeutics ,  Society of Neurosciences ,  日本消化器療学会 ,  日本薬理学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM